Nanomedicine in Organ Transplantation: From Graft Preservation and Repair to Immunomodulation and Monitoring
Open Access
- 1 January 2026
- journal article
- review article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (7) , 3286-3320
Abstract
Organ transplantation remains a life-saving intervention for end-stage organ failure. However, its long-term success has been constrained by a few critical challenges, including few noninvasive diagnostic technologies for graft assessment, a lack of effective organ preservation and rewarming techniques to mitigate ischemic damage, the issue of ischemia-reperfusion injury (IRI), the risk of immune-mediated rejection and the requirement of advanced postoperative management. Nanomedicine has been explored for overcoming these challenges for organ transplantation. A myriad of polymeric, inorganic and hybrid nanocarriers have been employed for nanomedicine. Targeting and stimuli-responsive nanomedicine has been developed to improve drug distribution and enhance its therapeutic/diagnostic efficacy. Nanomedicine has been applied for rewarming of large-sized organs, IRI mitigation, immunomodulation, and real-time monitoring. This review examines the mechanisms, elaborates design principles, and covers the application of nanomedicine in organ transplantation at stages of pre- to post-transplantation. The challenges in clinical translation of nanomedicine are discussed and future research directions are proposed. This review will provide a consolidated framework for the development and application of nanomedicine for organ transplantation, ultimately improving the quality of life of transplant recipients.Keywords
This publication has 195 references indexed in Scilit:
- Machine Perfusion of Donor Livers for Transplantation: A Proposal for Standardized Nomenclature and Reporting GuidelinesAmerican Journal of Transplantation, 2016
- Lymph node – an organ for T‐cell activation and pathogen defenseImmunological Reviews, 2016
- Principles of nanoparticle design for overcoming biological barriers to drug deliveryNature Biotechnology, 2015
- Damage‐associated molecular pattern–activated neutrophil extracellular trap exacerbates sterile inflammatory liver injuryHepatology, 2015
- Novel therapeutic and diagnostic management of heart transplant patients2015
- Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis2013
- Facile preparation of heparin/CaCO3/CaP hybrid nano-carriers with controllable size for anticancer drug deliveryColloids and Surfaces B: Biointerfaces, 2013
- The journey of a drug-carrier in the body: An anatomo-physiological perspectiveJournal of Controlled Release, 2012
- ASSESSMENT OF SERUM MATRIX METALLOPROTEINASES MMP-2 AND MMP-9 AFTER HUMAN LIVER TRANSPLANTATION: INCREASED SERUM MMP-9 LEVEL IN ACUTE REJECTIONTransplantation, 2004
- Spleen Capture of Nanoparticles: Influence of Animal Species and Surface CharacteristicsPharmaceutical Research, 1999